These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14522116)

  • 1. A novel delivery system for amphotericin B with lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Seki J
    Int J Pharm; 2003 Oct; 265(1-2):37-45. PubMed ID: 14522116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Sep; 263(1-2):51-60. PubMed ID: 12954180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid formulation as a drug carrier for drug delivery.
    Tomii Y
    Curr Pharm Des; 2002; 8(6):467-74. PubMed ID: 12069383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
    Matot I; Pizov R
    Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.
    Bhamra R; Sa'ad A; Bolcsak LE; Janoff AS; Swenson CE
    Antimicrob Agents Chemother; 1997 May; 41(5):886-92. PubMed ID: 9145839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.
    Kagan L; Gershkovich P; Wasan KM; Mager DE
    AAPS J; 2011 Jun; 13(2):255-64. PubMed ID: 21431453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3719-23. PubMed ID: 12435667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics characterization of liposomal amphotericin B: investigation of clearance process and drug interaction potential.
    Matsui S; Imai S; Yabuki M; Komuro S
    Arzneimittelforschung; 2009; 59(9):461-70. PubMed ID: 19856794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and Fungizone after repeated dosing in rats.
    Wang LH; Fielding RM; Smith PC; Guo LS
    Pharm Res; 1995 Feb; 12(2):275-83. PubMed ID: 7784345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.
    Italia JL; Yahya MM; Singh D; Ravi Kumar MN
    Pharm Res; 2009 Jun; 26(6):1324-31. PubMed ID: 19214716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus.
    Otsubo T; Maesaki S; Hossain MA; Yamamoto Y; Tomono K; Tashiro T; Seki J; Tomii Y; Sonoke S; Kohno S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):471-5. PubMed ID: 10049253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.